During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiomepost discussed with Anna Chwalibóg, Chief Product Officer at Integral Solutions, about the opportunity to develop next-generation microbiome-based therapeutics for mental health and cognitive enhancement using, in particular, CRISPR genome engineering.